HHS announces standard definition for opioid withdrawal in infants

Feb 01, 2022 - 11:58 AM
HHS Logo web sized 900x400

The Department of Health and Human Services yesterday announced a standard clinical definition for opioid withdrawal in infants. Recently published in the Journal of Pediatrics, the definition includes prenatal exposure and at least two of the most common clinical signs of withdrawal (excessive crying, fragmented sleep, tremors, increased muscle tone or gastrointestinal dysfunction). 

“As a pediatrician, I have seen the need for a standard clinical definition for opioid withdrawal in neonates, and am excited to see this step in improving care for infants and their families as part of the HHS Overdose Prevention Strategy,” said HHS Assistant Secretary for Health ADM Rachel Levine. “I look forward to working across all health sectors to get this definition adopted into clinical practice.”
 

Related News Articles

Headline
Overdose deaths dropped an estimated 27% in 2024
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
FDA approves first-in-class non-opioid painkiller 
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
AHA podcast: Thinking Outside the Box to Reduce Behavioral Health Stigma and Disparities 
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
'Take Back Day' Oct. 28 to dispose safely of prescription drugs
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Agencies target unapproved pharmaceutical products from India
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…